Genenta Science S p a
Officers & Directors
Pierluigi Paracchi, age 52, serves as Chief Executive Officer, Chairman of the Board of Directors, and General Manager. He has over 15 years of experience as an investor and director in life science companies, including founding and leading Quantica SGR as CEO. His previous roles include senior positions at Axòn Capital, Sofinnova Partners, and AurorA Science. Paracchi was a board member and investor in Ethical Oncology Science, which was acquired in 2013 for $470 million. He is a member of the Assobiotec Steering Committee and holds board positions as non-executive Chairman of Altheia Science and director of Lipogems International. He is also a venture partner with AurorA Science.
Richard B. Slansky, age 68, is the Chief Financial Officer. He has over 30 years of CFO experience in biopharmaceutical, diagnostic, high-tech, and life science companies, including Biological Dynamics, OncoSec Medical, GenMark Diagnostics (now part of Roche), and C-N Biosciences (now part of Millipore Sigma, a division of Merck KGaA). Slansky has worked with public and private healthcare and technology companies at various growth stages and serves on boards of private companies in life science, aerospace, and real estate sectors.
Francesco Galimi, M.D., Ph.D., age 58, is the Acting Chief Medical Officer and Head of Development. He has over 30 years of healthcare research and development experience with leadership roles in private and public biotechs and large pharmaceutical companies. His previous positions include Senior Vice President and Chief Medical Officer at Adicet Bio, Global Program General Manager at Amgen, Head of Clinical Development at Onyx Pharmaceuticals, and Executive Medical Leader at GNF/Novartis. Galimi holds an M.D. and Ph.D. in Oncology from the University of Torino Medical School and completed post-doctoral research at the Salk Institute.
Genenta Science S p a currently has 7 employees.
|
